Bibliography
- Global Initiative for Asthma. Global strategy for asthma management and prevention, MD, USA: National Institute of Health; Publication No. 02–3659 (2002).
- Miller RL , HoSM: Environmental epigenetics and asthma: current concepts and call for studies.Am. J. Respir. Crit. Care Med.177 , 567–573 (2008).
- Guidelines for management of asthma at primary and secondary levels of health care in India: WHO – Government of India Collaborative Programme. 1–43 (2005).
- Hall IP : Pharmacogenetics of asthma.Eur. Respir. J.15 , 449–451 (2000).
- Weiss ST , LitonjuaAA, LangeC et al.: Overview of the pharmacogenetics of asthma treatment.Pharmacogenomics J.6(5) , 311–326 (2006).
- Pastinen T , SladekR, GurdS et al.: A survey of genetic and epigenetic variation affecting human gene expression.Physiol. Genomics16(2) , 184–193 (2004).
- Silverman R : Treatment of acute asthma: a new look at the old and at the new.Clin. Chest Med.21 , 361–379 (2000).
- Reihsaus E , InnisM, MacIntyreN, LiggettSB: Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects.Am. J. Respir. Cell Mol. Biol.8(3) , 334–339 (1993).
- Liggett SB : Polymorphisms of the β2-adrenergic receptor and asthma.Am. J. Respir. Crit. Care Med.156 , S156–S162 (1997).
- Martinez FD , GravesPE, BaldiniM, SolomonS, EricksonR: Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing.J. Clin. Invest.100(12) , 3184–3188 (1997).
- Drysdale CM , McGrawDW, StackCB et al.: Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.Proc. Natl Acad. Sci. USA97(19) , 10483–10488 (2000).
- Choudhry S , UngN, AvilaPC et al.: Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.Am. J. Respir. Crit. Care Med.171(6) , 563–570 (2005).
- Kukreti R , BhatnagarP, B-RaoC et al.: β2-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics.Pharmacogenomics6(4) , 399–410 (2005).
- Israel E , ChinchilliVM, FordJG et al: Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trial. Lancet (364) , 1505–1512 (2004).
- British Thoracic Society. The British guidelines on asthma management: Review and position statement. Thorax52 (Suppl. 1) , 1–21 (1997).
- Weiss ST , LakeSL, SilvermanES et al.: Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses.Proc. Am. Thorac. Soc.1(4) , 364–367 (2004).
- Tantisira KG , HwangES, RabyBA et al.: TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids.Proc. Natl Acad. Sci. USA101(52) , 18099–18104 (2004).
- Barnes N : New drugs for asthma.Practitioner237 , 870–873 (1993).
- Barnes NC , KuitertLM: Drugs affecting the leukotriene pathway in asthma.Br. J. Clin. Pract.49 , 262–266 (1995).
- Barnes N : Leukotriene receptor antagonists: clinical effects.J. R. Soc. Med.90 , 200–204 (1997).
- Ito K , LimS, CaramoriG et al.: A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression.Proc. Natl Acad. Sci. USA99(13) , 8921–8926 (2002).
- Mak JC , BaraniukJN, BarnesPJ: Localization of muscarinic receptor subtype mRNAs in human lung.Am. J. Respir. Cell Mol. Biol.7(3) , 344–348 (1992).
- Roffel AF , ElzingaCRS, ZaagsmaJ: Muscarinic M3 receptor mediates contraction of human central and peripheral airway smooth muscle.Pulmon. Pharmacol.3 , 47–51 (1990).
- Fenech AG , EbejerMJ, FeliceAE, Ellul-MicallefR, HallIP: Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects.Br. J. Pharmacol.133(1) , 43–48 (2001).
- Yamamoto T , YamashitaN, KuwabaraM et al.: Mutation screening of the muscarinic M2 and M3 receptor genes in asthmatics, outgrow subjects, and normal controls.Ann. Genet.45(3) , 109–113 (2002).
- Fenech AG , BillingtonCK, SwanC et al.: Novel polymorphisms influencing transcription of the human CHRM2 gene in airway smooth muscle.Am. J. Respir. Cell Mol. Biol.30(5) , 678–686 (2004).
- Lima JJ , BlakeKV, TantisiraKG, WeissST: Pharmacogenetics of asthma.Curr. Opin. Pulm. Med.15(1) , 57–62 (2009)
- Bhatnagar P , GuleriaR, KukretiR: Variable therapeutic response in asthma: a genetic perspective.Personalized Medicine3(1) , 61–78 (2006).
- Brahmachari SK , MajumderPP, MukerjiM et al.; Indian Genome Variation Consortium: Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet.87 , 3–20 (2008).
- Séguin B , HardyBJ, SingerPA, DaarAS: Genomic medicine and developing countries: creating a room of their own.Nature Rev. Genet.9 , 487–494 (2008).